HOME >> MEDICINE >> NEWS
Smallpox vaccine may cause harmless skin rashes

People who have never received a smallpox vaccination may develop any of a variety of benign skin rashes a few days after getting vaccinated for smallpox that should not be confused with a more serious complication of the vaccine, according to an article in the April 1 issue of Clinical Infectious Diseases, now available online.

Vaccinia is a virus used to immunize people against smallpox. The study examined 350 adult volunteers, 250 of whom were "vaccinia-nave," or had never been vaccinated for smallpox before, and 100 of whom were "vaccinia-experienced," or had previously received a smallpox vaccination. Of the vaccinia-nave, 3.6 percent developed some type of skin rash 6-19 days after being vaccinated. Symptoms usually included itching, redness and small bumps on the skin, and some patients also complained of headaches.

The five different types of rashes described in the article were all "self-limiting"--that is, they cleared up on their own after one to three weeks--and were not accompanied by fever or any other serious symptoms. The harmlessness of the vaccinia-associated skin rashes makes the findings important, according to Dr. Richard Greenberg, lead author of the study, which took place from July of 2002 to February of 2003.

"Physicians need to know that [the skin reactions] are benign and can be treated with medicines such as antihistamine," said Dr. Greenberg of the University of Kentucky School of Medicine. Doctors who realize that the rashes are not dangerous can offer reassurance to concerned patients and prescribe appropriate medications for symptom relief.

A physician who is unaware of the possibility for a benign skin reaction might wrongly assume that a patient's rash was the development of one of the more dangerous vaccinial lesions. "The concern is that the physician would overreact," Dr. Greenberg said. "These skin reactions are rather dramatic, and if we're going to be vaccinating against smallpox, the physicia
'"/>

Contact: Diana Olson
dolson@idsociety.org
703-299-0201
Infectious Diseases Society of America
17-Mar-2004


Page: 1 2

Related medicine news :

1. Smallpox vaccine can be diluted and still be effective, expanding supply if needed
2. Smallpox outbreak response: Targeted vaccination may be almost as effective as mass vaccination
3. Pitt marks 50th anniversary of its Salk polio vaccine with reunion, scientific symposium
4. NIAID initiates trial of experimental avian flu vaccine
5. Study finds majority of women willing to accept cervical cancer vaccine for self and children
6. Invasive pneumonia and antibiotic resistance decreased after childhood vaccine introduced
7. Earlier use of prostate cancer vaccines urged by Hopkins scientists
8. Researchers close in on breast cancer vaccine
9. EuroVacc 02 HIV vaccine trial begins in February 2005
10. Varicella vaccine effective on chicken pox; Impact on herpes zoster unclear
11. Pathogen-mimicking vaccine as strategy for cancer therapy

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Smallpox vaccine may cause harmless skin rashes

(Date:10/20/2014)... 20, 2014 With a mere 19 ... Crist made a brief fundraising stop at the ... , Fresh from a debate last night with his ... stage for the first seven minutes because Crist had ... described the incident in one word: "weird." , Before ...
(Date:10/20/2014)... 2014 ASCNYC (ascnyc.org) is a ... New Yorkers living with HIV/AIDS and other chronic ... recovery and self-sufficiency. Each year, ASCNYC spotlights selected ... through their tireless efforts. , Savills Studley ... has been selected as this year’s honoree for ...
(Date:10/20/2014)... IN (PRWEB) October 20, 2014 ... Start, a secure cloud solution that enables healthcare ... of the ultimate healthcare-specific customer relationship management (“CRM”) ... meet the unique needs of the healthcare industry, ... experience for providers and patients by combining healthcare ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 My Clients ... management software application. The new module enables easy ... receive full life-cycle quality care. , This application allows ... within their practice, attach a to-do item to a ... and even set up reoccurring reminders for follow-ups. ...
(Date:10/20/2014)... 20, 2014 Myoderm ... Assistant Director of their CentralSource service. ... the innovative turnkey drug sourcing, distribution, and management ... over 12 years of industry experience, in both ... the peak of their international success to help ...
Breaking Medicine News(10 mins):Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 2Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 3Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2Health News:My Clients Plus Announces New Workflow Management Software 2Health News:Myoderm Hires Matthew Voicheck to Lead Turnkey Drug Sourcing Service 2
(Date:10/17/2014)... 17, 2014 With the recent changes ... has come across several challenges in creating and ... globalization.  The Medical Affairs ... to providing benchmarking and best practices across critical ... a service composed of three stages: 1) member-driven ...
(Date:10/17/2014)... Research ... addition of the  "China Interventional Cardiovascular Device ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) The ... China impacted by accelerated aging ... dietary habit, way of working and other ...
(Date:10/17/2014)... , October 17, 2014 Investor-Edge ... Inc. (NASDAQ: ARNA ), NPS Pharmaceuticals Inc. ... XOMA ), Momenta Pharmaceuticals Inc. (NASDAQ: ... Free research on these five companies can be accessed ... on Thursday, October 16, 2014, ended on a mixed ...
Breaking Medicine Technology:Early Key Findings from the Medical Affairs Consortium Research 2China Interventional Cardiovascular Device Industry Report 2014-2017 2China Interventional Cardiovascular Device Industry Report 2014-2017 3Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 2Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 3Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 4Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 5
Cached News: